title: Recurrent scrotal hemangiomas during treatment with sunitinib.
authors.affiliation: Campus Bio-Medico University of Rome, Rome, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Tonini
authors.forename: Salvatore
authors.initials: S
authors.lastname: Intagliata
authors.forename: Barbara
authors.initials: B
authors.lastname: Cagli
authors.forename: Francesco
authors.initials: F
authors.lastname: Segreto
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Perrone
authors.forename: Andrea
authors.initials: A
authors.lastname: Onetti Muda
authors.forename: Daniele
authors.initials: D
authors.lastname: Santini
authors.forename: Paolo
authors.initials: P
authors.lastname: Persichetti
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D004164:Diphosphonates / Q000627:therapeutic use; D005834:Genital Neoplasms, Male / Q000139:chemically induced* / Q000473:pathology; D006391:Hemangioma / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000009:adverse effects*; D012008:Recurrence; D012611:Scrotum / Q000473:pathology*; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D000077210:Sunitinib; D000077211:Zoledronic Acid
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D007211:Indoles; D011758:Pyrroles; D000077211:Zoledronic Acid; D000077210:Sunitinib